Merck KGaA MKGAF
170.00 USD +2.55 (+1.52%)
Nov 4, 2026, 9:34 AM EST
170.00 Day range 170.00
116.68 52-week range 175.56
- YTD
- +15.18%
- 1 year
- +35.64%
News
benzinga.com Why Is Silence Therapeutics Stock Skyrocketing Monday? Silence Therapeutics (SLN) leaps 126% on a $1.3B cash acquisition by Merck KGaA at $20 per ADS. Deal expected to close Q1 2027.
wsj.com Germany's Merck to Buy U.K. Biotech Silence Therapeutics for $1.3 Billion Merck said it is offering $20 in cash for each American depositary share for Nasdaq-listed Silence Therapeutics, more than double the target's closing price as of Friday.
defenseworld.net Merck KGaA (OTCMKTS:MKGAF) Shares Gap Down – Should You Sell? Merck KGaA (OTCMKTS:MKGAF - Get Free Report)'s share price gapped down before the market opened on Monday. The stock had previously closed at $160.7520, but opened at $153.9040. Merck KGaA shares…
defenseworld.net 363,066 Shares in Merck KGaA $MKGAF Purchased by Beacon Pointe Advisors LLC Beacon Pointe Advisors LLC bought a new stake in Merck KGaA (OTCMKTS:MKGAF) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange…
defenseworld.net Blue Edge Capital LLC Decreases Stake in Merck KGaA $MKGAF Blue Edge Capital LLC lowered its holdings in Merck KGaA (OTCMKTS:MKGAF) by 39.1% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.…
defenseworld.net Bamco Inc. NY Buys Shares of 22,000 Merck KGaA $MKGAF Bamco Inc. NY purchased a new position in shares of Merck KGaA (OTCMKTS:MKGAF) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).…
defenseworld.net ADAR1 Capital Management LLC Invests $403,000 in Merck KGaA $MKGAF ADAR1 Capital Management LLC acquired a new position in shares of Merck KGaA (OTCMKTS:MKGAF) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission…
defenseworld.net Ancora Advisors LLC Invests $2.69 Million in Merck KGaA $MKGAF Ancora Advisors LLC acquired a new stake in Merck KGaA (OTCMKTS:MKGAF) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission…
defenseworld.net Ausdal Financial Partners Inc. Takes Position in Merck KGaA $MKGAF Ausdal Financial Partners Inc. bought a new position in Merck KGaA (OTCMKTS:MKGAF) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor bought…
defenseworld.net AFT Forsyth & Company Inc. Invests $822,000 in Merck KGaA $MKGAF AFT Forsyth and Company Inc. bought a new position in shares of Merck KGaA (OTCMKTS:MKGAF) in the second quarter, according to the company in its most recent disclosure with the Securities and…
defenseworld.net 7,331,418 Shares in Merck KGaA $MKGAF Purchased by Barrow Hanley Mewhinney & Strauss LLC Barrow Hanley Mewhinney and Strauss LLC bought a new stake in shares of Merck KGaA (OTCMKTS:MKGAF) in the undefined quarter, according to its most recent filing with the Securities and Exchange…
defenseworld.net Barbara Oil Co. Makes New Investment in Merck KGaA $MKGAF Barbara Oil Co. acquired a new position in Merck KGaA (OTCMKTS:MKGAF) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.…
defenseworld.net Ally Financial Inc. Takes $4.50 Million Position in Merck KGaA $MKGAF Ally Financial Inc. bought a new position in shares of Merck KGaA (OTCMKTS:MKGAF) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange…
defenseworld.net Emerald Investment Advisers LLC Makes New Investment in Merck KGaA $MKGAF Emerald Investment Advisers LLC purchased a new position in shares of Merck KGaA (OTCMKTS:MKGAF) during the undefined quarter, according to the company in its most recent Form 13F filing with the…
benzinga.com Werewolf Therapeutics Takes Aim At Untapped Pain Market With Ambros Deal Werewolf Therapeutics and Ambros Therapeutics merge in an all-stock deal with $150M in financing to advance Phase 3 CRPS-1 candidate.
defenseworld.net B. Metzler seel. Sohn & Co. AG Takes Position in Merck KGaA $MKGAF B. Metzler seel. Sohn and Co. AG bought a new position in shares of Merck KGaA (OTCMKTS:MKGAF) during the undefined quarter, according to its most recent Form 13F filing with the SEC. The…
defenseworld.net Bell & Brown Wealth Advisors LLC Invests $5.66 Million in Merck KGaA $MKGAF Bell and Brown Wealth Advisors LLC purchased a new position in shares of Merck KGaA (OTCMKTS:MKGAF) during the undefined quarter, according to the company in its most recent disclosure with the SEC.…
defenseworld.net August Group Capital Ltd Takes Position in Merck KGaA $MKGAF August Group Capital Ltd purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor…
defenseworld.net 9,092 Shares in Merck KGaA $MKGAF Acquired by Asahi Life Asset Management CO. LTD. Asahi Life Asset Management CO. LTD. acquired a new stake in Merck KGaA (OTCMKTS:MKGAF) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange…
defenseworld.net BOK Financial Private Wealth Inc. Acquires Shares of 4,043 Merck KGaA $MKGAF BOK Financial Private Wealth Inc. bought a new position in Merck KGaA (OTCMKTS:MKGAF) during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange…
zacks.com Merck KGaA (MKKGY) Misses Q2 Earnings Estimates Merck KGaA (MKKGY) came out with quarterly earnings of $0.26 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.57 per share a year ago.
businesswire.com Evinova Launches Strategic Partnership with Merck KGaA, Darmstadt, Germany to Define the Future of Clinical Development BAAR, Switzerland--(BUSINESS WIRE)--Evinova, a global leader in AI-native clinical development technology, today announced a new multi-year strategic collaboration to accelerate global clinical…
benzinga.com Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover Private equity giants circle Qiagen (QGEN) with potential bids of $50/share. Get the details on the molecular diagnostics buyout.
benzinga.com Acuity Posts Strong Q3 Results, Joins BlackBerry, MillerKnoll, Qualcomm And Other Big Stocks Moving Higher On Thursday Dow Jones index gained 200 points; Acuity Inc (NYSE: AYI) reported better-than-expected financial results, shares rose 17.1%; other big stocks also gained.
benzinga.com Merck Germany Lands Bio-Techne In $11.3 Billion Cash Deal Merck KGaA is acquiring Bio-Techne in an $11.3B all-cash deal to expand its life science, diagnostics, and bioprocessing footprint.
benzinga.com Elizabeth Warren Calls Trump's '600%' Drug Price Claim Mathematically Impossible: 'His Promise Is As Empty As…' Sen. Warren challenges Trump's 600% TrumpRx drug price claim using a glass of water.
benzinga.com Large Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock Surges Inhibrx explores spin-off of INBRX-106 amid Big Pharma interest, with potential valuation exceeding $9 billion pending trial outcomes.
benzinga.com Invo Fertility Stock Is Plunging After White House Announcement INVO Fertility Inc (NASDAQ:IVF) shares are trading lower on Thursday as investors book profits following White House announcements aimed at making fertility treatments more affordable and accessible.
benzinga.com FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, and other conditions.
benzinga.com WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio? Top performing mid-cap stocks last week: WRD (+97.62%), GDS (+43.45%), SWTX (+42.58%), RXRX (+40.59%), SOC (+39.09%), WGS (+28.23%), VNET (+28.22%), NSP (+25.99%), CRSP (+25.21%), AXSM (+24.01%)
benzinga.com Stocks That Hit 52-Week Highs On Tuesday 
benzinga.com Stocks That Hit 52-Week Highs On Friday - benzinga.com Stocks That Hit 52-Week Highs On Thursday